NCT01826877View on ClinicalTrials.gov

Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 14, 2013

Primary Completion Date

July 3, 2018

Study Completion Date

May 27, 2021

Conditions
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
Interventions
BIOLOGICAL

AdGMCAIX-transduced autologous dendritic cells

Given ID

BIOLOGICAL

therapeutic autologous dendritic cells

Given ID

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

90095

Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

Kite, A Gilead Company

INDUSTRY

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT01826877 - Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter